Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.
Identifieur interne : 001C78 ( PubMed/Checkpoint ); précédent : 001C77; suivant : 001C79Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.
Auteurs : Yi-Ming Shao [République populaire de Chine] ; Wen-Bin Yang ; Hung-Pin Peng ; Min-Feng Hsu ; Keng-Chang Tsai ; Tun-Hsun Kuo ; Andrew H-J Wang ; Po-Huang Liang ; Chun-Hung Lin ; An-Suei Yang ; Chi-Huey WongSource :
- Chembiochem : a European journal of chemical biology [ 1439-4227 ] ; 2007.
Descripteurs français
- KwdFr :
- Chimie pharmaceutique (), Conception de médicament, Conformation des protéines, Conformation moléculaire, Cristallisation, Cristallographie aux rayons X (), Cysteine endopeptidases, Inhibiteurs de protéases (pharmacologie), Inhibiteurs de protéases (synthèse chimique), Liaison hydrogène, Ligands, Modèles chimiques, Protéines virales (antagonistes et inhibiteurs), Rayons X, Virus du SRAS (enzymologie).
- MESH :
- antagonistes et inhibiteurs : Protéines virales.
- enzymologie : Virus du SRAS.
- pharmacologie : Inhibiteurs de protéases.
- synthèse chimique : Inhibiteurs de protéases.
- Chimie pharmaceutique, Conception de médicament, Conformation des protéines, Conformation moléculaire, Cristallisation, Cristallographie aux rayons X, Cysteine endopeptidases, Liaison hydrogène, Ligands, Modèles chimiques, Rayons X.
English descriptors
- KwdEn :
- Chemistry, Pharmaceutical (methods), Crystallization, Crystallography, X-Ray (methods), Cysteine Endopeptidases, Drug Design, Hydrogen Bonding, Ligands, Models, Chemical, Molecular Conformation, Protease Inhibitors (chemical synthesis), Protease Inhibitors (pharmacology), Protein Conformation, SARS Virus (enzymology), Viral Proteins (antagonists & inhibitors), X-Rays.
- MESH :
- chemical , antagonists & inhibitors : Viral Proteins.
- chemical , chemical synthesis : Protease Inhibitors.
- chemical , pharmacology : Protease Inhibitors.
- chemical : Cysteine Endopeptidases, Ligands.
- enzymology : SARS Virus.
- methods : Chemistry, Pharmaceutical, Crystallography, X-Ray.
- Crystallization, Drug Design, Hydrogen Bonding, Models, Chemical, Molecular Conformation, Protein Conformation, X-Rays.
DOI: 10.1002/cbic.200700254
PubMed: 17722121
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:17722121Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.</title>
<author><name sortKey="Shao, Yi Ming" sort="Shao, Yi Ming" uniqKey="Shao Y" first="Yi-Ming" last="Shao">Yi-Ming Shao</name>
<affiliation wicri:level="1"><nlm:affiliation>Genomics Research Center, Academia Sinica, No. 128, Sec. 2, Academia Rd., Taipei City 115, Taiwan, ROC.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country>
<wicri:regionArea>Genomics Research Center, Academia Sinica, No. 128, Sec. 2, Academia Rd., Taipei City 115, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yang, Wen Bin" sort="Yang, Wen Bin" uniqKey="Yang W" first="Wen-Bin" last="Yang">Wen-Bin Yang</name>
</author>
<author><name sortKey="Peng, Hung Pin" sort="Peng, Hung Pin" uniqKey="Peng H" first="Hung-Pin" last="Peng">Hung-Pin Peng</name>
</author>
<author><name sortKey="Hsu, Min Feng" sort="Hsu, Min Feng" uniqKey="Hsu M" first="Min-Feng" last="Hsu">Min-Feng Hsu</name>
</author>
<author><name sortKey="Tsai, Keng Chang" sort="Tsai, Keng Chang" uniqKey="Tsai K" first="Keng-Chang" last="Tsai">Keng-Chang Tsai</name>
</author>
<author><name sortKey="Kuo, Tun Hsun" sort="Kuo, Tun Hsun" uniqKey="Kuo T" first="Tun-Hsun" last="Kuo">Tun-Hsun Kuo</name>
</author>
<author><name sortKey="Wang, Andrew H J" sort="Wang, Andrew H J" uniqKey="Wang A" first="Andrew H-J" last="Wang">Andrew H-J Wang</name>
</author>
<author><name sortKey="Liang, Po Huang" sort="Liang, Po Huang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
</author>
<author><name sortKey="Lin, Chun Hung" sort="Lin, Chun Hung" uniqKey="Lin C" first="Chun-Hung" last="Lin">Chun-Hung Lin</name>
</author>
<author><name sortKey="Yang, An Suei" sort="Yang, An Suei" uniqKey="Yang A" first="An-Suei" last="Yang">An-Suei Yang</name>
</author>
<author><name sortKey="Wong, Chi Huey" sort="Wong, Chi Huey" uniqKey="Wong C" first="Chi-Huey" last="Wong">Chi-Huey Wong</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17722121</idno>
<idno type="pmid">17722121</idno>
<idno type="doi">10.1002/cbic.200700254</idno>
<idno type="wicri:Area/PubMed/Corpus">001D38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D38</idno>
<idno type="wicri:Area/PubMed/Curation">001D38</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001D38</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001C78</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001C78</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.</title>
<author><name sortKey="Shao, Yi Ming" sort="Shao, Yi Ming" uniqKey="Shao Y" first="Yi-Ming" last="Shao">Yi-Ming Shao</name>
<affiliation wicri:level="1"><nlm:affiliation>Genomics Research Center, Academia Sinica, No. 128, Sec. 2, Academia Rd., Taipei City 115, Taiwan, ROC.</nlm:affiliation>
<country xml:lang="fr" wicri:curation="lc">République populaire de Chine</country>
<wicri:regionArea>Genomics Research Center, Academia Sinica, No. 128, Sec. 2, Academia Rd., Taipei City 115, Taiwan</wicri:regionArea>
<wicri:noRegion>Taiwan</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Yang, Wen Bin" sort="Yang, Wen Bin" uniqKey="Yang W" first="Wen-Bin" last="Yang">Wen-Bin Yang</name>
</author>
<author><name sortKey="Peng, Hung Pin" sort="Peng, Hung Pin" uniqKey="Peng H" first="Hung-Pin" last="Peng">Hung-Pin Peng</name>
</author>
<author><name sortKey="Hsu, Min Feng" sort="Hsu, Min Feng" uniqKey="Hsu M" first="Min-Feng" last="Hsu">Min-Feng Hsu</name>
</author>
<author><name sortKey="Tsai, Keng Chang" sort="Tsai, Keng Chang" uniqKey="Tsai K" first="Keng-Chang" last="Tsai">Keng-Chang Tsai</name>
</author>
<author><name sortKey="Kuo, Tun Hsun" sort="Kuo, Tun Hsun" uniqKey="Kuo T" first="Tun-Hsun" last="Kuo">Tun-Hsun Kuo</name>
</author>
<author><name sortKey="Wang, Andrew H J" sort="Wang, Andrew H J" uniqKey="Wang A" first="Andrew H-J" last="Wang">Andrew H-J Wang</name>
</author>
<author><name sortKey="Liang, Po Huang" sort="Liang, Po Huang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
</author>
<author><name sortKey="Lin, Chun Hung" sort="Lin, Chun Hung" uniqKey="Lin C" first="Chun-Hung" last="Lin">Chun-Hung Lin</name>
</author>
<author><name sortKey="Yang, An Suei" sort="Yang, An Suei" uniqKey="Yang A" first="An-Suei" last="Yang">An-Suei Yang</name>
</author>
<author><name sortKey="Wong, Chi Huey" sort="Wong, Chi Huey" uniqKey="Wong C" first="Chi-Huey" last="Wong">Chi-Huey Wong</name>
</author>
</analytic>
<series><title level="j">Chembiochem : a European journal of chemical biology</title>
<idno type="ISSN">1439-4227</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chemistry, Pharmaceutical (methods)</term>
<term>Crystallization</term>
<term>Crystallography, X-Ray (methods)</term>
<term>Cysteine Endopeptidases</term>
<term>Drug Design</term>
<term>Hydrogen Bonding</term>
<term>Ligands</term>
<term>Models, Chemical</term>
<term>Molecular Conformation</term>
<term>Protease Inhibitors (chemical synthesis)</term>
<term>Protease Inhibitors (pharmacology)</term>
<term>Protein Conformation</term>
<term>SARS Virus (enzymology)</term>
<term>Viral Proteins (antagonists & inhibitors)</term>
<term>X-Rays</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Chimie pharmaceutique ()</term>
<term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Conformation moléculaire</term>
<term>Cristallisation</term>
<term>Cristallographie aux rayons X ()</term>
<term>Cysteine endopeptidases</term>
<term>Inhibiteurs de protéases (pharmacologie)</term>
<term>Inhibiteurs de protéases (synthèse chimique)</term>
<term>Liaison hydrogène</term>
<term>Ligands</term>
<term>Modèles chimiques</term>
<term>Protéines virales (antagonistes et inhibiteurs)</term>
<term>Rayons X</term>
<term>Virus du SRAS (enzymologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Protease Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Protease Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Cysteine Endopeptidases</term>
<term>Ligands</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Chemistry, Pharmaceutical</term>
<term>Crystallography, X-Ray</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Inhibiteurs de protéases</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Inhibiteurs de protéases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Crystallization</term>
<term>Drug Design</term>
<term>Hydrogen Bonding</term>
<term>Models, Chemical</term>
<term>Molecular Conformation</term>
<term>Protein Conformation</term>
<term>X-Rays</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Chimie pharmaceutique</term>
<term>Conception de médicament</term>
<term>Conformation des protéines</term>
<term>Conformation moléculaire</term>
<term>Cristallisation</term>
<term>Cristallographie aux rayons X</term>
<term>Cysteine endopeptidases</term>
<term>Liaison hydrogène</term>
<term>Ligands</term>
<term>Modèles chimiques</term>
<term>Rayons X</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17722121</PMID>
<DateCompleted><Year>2008</Year>
<Month>01</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1439-4227</ISSN>
<JournalIssue CitedMedium="Print"><Volume>8</Volume>
<Issue>14</Issue>
<PubDate><Year>2007</Year>
<Month>Sep</Month>
<Day>24</Day>
</PubDate>
</JournalIssue>
<Title>Chembiochem : a European journal of chemical biology</Title>
<ISOAbbreviation>Chembiochem</ISOAbbreviation>
</Journal>
<ArticleTitle>Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors.</ArticleTitle>
<Pagination><MedlinePgn>1654-7</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shao</LastName>
<ForeName>Yi-Ming</ForeName>
<Initials>YM</Initials>
<AffiliationInfo><Affiliation>Genomics Research Center, Academia Sinica, No. 128, Sec. 2, Academia Rd., Taipei City 115, Taiwan, ROC.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Wen-Bin</ForeName>
<Initials>WB</Initials>
</Author>
<Author ValidYN="Y"><LastName>Peng</LastName>
<ForeName>Hung-Pin</ForeName>
<Initials>HP</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hsu</LastName>
<ForeName>Min-Feng</ForeName>
<Initials>MF</Initials>
</Author>
<Author ValidYN="Y"><LastName>Tsai</LastName>
<ForeName>Keng-Chang</ForeName>
<Initials>KC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kuo</LastName>
<ForeName>Tun-Hsun</ForeName>
<Initials>TH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Andrew H-J</ForeName>
<Initials>AH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Liang</LastName>
<ForeName>Po-Huang</ForeName>
<Initials>PH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lin</LastName>
<ForeName>Chun-Hung</ForeName>
<Initials>CH</Initials>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>An-Suei</ForeName>
<Initials>AS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wong</LastName>
<ForeName>Chi-Huey</ForeName>
<Initials>CH</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Chembiochem</MedlineTA>
<NlmUniqueID>100937360</NlmUniqueID>
<ISSNLinking>1439-4227</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="C099456">3C-like proteinase, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002626" MajorTopicYN="N">Chemistry, Pharmaceutical</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003460" MajorTopicYN="N">Crystallization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018360" MajorTopicYN="N">Crystallography, X-Ray</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015195" MajorTopicYN="N">Drug Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006860" MajorTopicYN="N">Hydrogen Bonding</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008956" MajorTopicYN="N">Models, Chemical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011487" MajorTopicYN="N">Protein Conformation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014965" MajorTopicYN="N">X-Rays</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>1</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17722121</ArticleId>
<ArticleId IdType="doi">10.1002/cbic.200700254</ArticleId>
<ArticleId IdType="pmc">PMC7162026</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Curr Opin Struct Biol. 2005 Dec;15(6):664-72</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16263266</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem. 2004 Aug 1;12(15):4081-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15246086</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem Lett. 2005 Jun 15;15(12):3058-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15896959</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chem Biol. 2006 Mar;13(3):261-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16638531</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Curr Top Microbiol Immunol. 2005;287:57-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15609509</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2005 Jun 30;48(13):4469-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15974598</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 2003 Sep;84(Pt 9):2305-2315</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12917450</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2004 Dec 2;47(25):6113-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15566280</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Mol Biol. 2005 Nov 11;353(5):1137-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16219322</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):939-44</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9448264</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Nat Rev Microbiol. 2003 Dec;1(3):209-18</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15035025</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chem Biol. 2004 Sep;11(9):1293-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15380189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15226499</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2003 Oct 9;46(21):4572-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14521419</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Annu Rep Med Chem. 2007 Feb 1;41:183-196</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19649165</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Med Chem. 2005 Nov 3;48(22):6767-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16250632</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Bioorg Med Chem. 2005 Sep 1;13(17):5240-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15994085</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Chembiochem. 2006 Jul;7(7):1048-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16688706</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>PLoS Biol. 2005 Oct;3(10):e324</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16128623</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Hsu, Min Feng" sort="Hsu, Min Feng" uniqKey="Hsu M" first="Min-Feng" last="Hsu">Min-Feng Hsu</name>
<name sortKey="Kuo, Tun Hsun" sort="Kuo, Tun Hsun" uniqKey="Kuo T" first="Tun-Hsun" last="Kuo">Tun-Hsun Kuo</name>
<name sortKey="Liang, Po Huang" sort="Liang, Po Huang" uniqKey="Liang P" first="Po-Huang" last="Liang">Po-Huang Liang</name>
<name sortKey="Lin, Chun Hung" sort="Lin, Chun Hung" uniqKey="Lin C" first="Chun-Hung" last="Lin">Chun-Hung Lin</name>
<name sortKey="Peng, Hung Pin" sort="Peng, Hung Pin" uniqKey="Peng H" first="Hung-Pin" last="Peng">Hung-Pin Peng</name>
<name sortKey="Tsai, Keng Chang" sort="Tsai, Keng Chang" uniqKey="Tsai K" first="Keng-Chang" last="Tsai">Keng-Chang Tsai</name>
<name sortKey="Wang, Andrew H J" sort="Wang, Andrew H J" uniqKey="Wang A" first="Andrew H-J" last="Wang">Andrew H-J Wang</name>
<name sortKey="Wong, Chi Huey" sort="Wong, Chi Huey" uniqKey="Wong C" first="Chi-Huey" last="Wong">Chi-Huey Wong</name>
<name sortKey="Yang, An Suei" sort="Yang, An Suei" uniqKey="Yang A" first="An-Suei" last="Yang">An-Suei Yang</name>
<name sortKey="Yang, Wen Bin" sort="Yang, Wen Bin" uniqKey="Yang W" first="Wen-Bin" last="Yang">Wen-Bin Yang</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Shao, Yi Ming" sort="Shao, Yi Ming" uniqKey="Shao Y" first="Yi-Ming" last="Shao">Yi-Ming Shao</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C78 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001C78 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:17722121 |texte= Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:17722121" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |